1 / 21

Program Goals

Program Goals. ADA/EASD 2012 Recommendations for Antihyperglycemic Therapy. DPP-4 Inhibitors: Benefits and Risks. DPP-4 Inhibitors: Large-Scale CV Safety Studies. DPP-4 Inhibitor CV Safety Study: SAVOR-TIMI 53. DPP-4 Inhibitor CV Safety Study: EXAMINE. SGLT-2 Inhibitors: Benefits.

star
Télécharger la présentation

Program Goals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Program Goals

  2. ADA/EASD 2012 Recommendations for Antihyperglycemic Therapy

  3. DPP-4 Inhibitors: Benefits and Risks

  4. DPP-4 Inhibitors: Large-Scale CV Safety Studies

  5. DPP-4 Inhibitor CV Safety Study: SAVOR-TIMI 53

  6. DPP-4 Inhibitor CV Safety Study: EXAMINE

  7. SGLT-2 Inhibitors: Benefits

  8. SGLT-2 Inhibitors: Risks & Adverse Effects

  9. Abbreviations

  10. Abbreviations (cont)

  11. References

  12. References (cont)

  13. References (cont)

  14. References (cont)

  15. References (cont)

  16. References (cont)

More Related